Last edition
News about "Olopatadine Hydrochloride Ophthalmic Solution "
Alembic Pharma Gets Tentative Approval for Olopatadine Hydrochloride Ophthalmic Solution
Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 percent (OTC) has an estimated market size of USD 22 million for twelve months.
Olopatadine Hydrochloride Ophthalmic Solution | 07/12/2024 | By Aishwarya
Glenmark Therapeutics Unveils Olopatadine Hydrochloride Ophthalmic Solution
Glenmark Therapeutics has launched Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1 percent (OTC) as compared to the active ingredient in Pataday Twice Daily Relief.
Olopatadine Hydrochloride Ophthalmic Solution | 20/08/2024 | By Aishwarya
Lupin Gets Tentative Approval from FDA for Olopatadine Hydrochloride Ophthalmic Solution
Lupin has received a tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7 percent (OTC).
Olopatadine Hydrochloride Ophthalmic Solution | 28/06/2024 | By Aishwarya | 220
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy